about
Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemideMonoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity.Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականին հրատարակուած գիտական յօդուած
@hyw
1990 թվականին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Biotransformation of moclobemide in humans
@ast
Biotransformation of moclobemide in humans
@en
Biotransformation of moclobemide in humans
@nl
type
label
Biotransformation of moclobemide in humans
@ast
Biotransformation of moclobemide in humans
@en
Biotransformation of moclobemide in humans
@nl
prefLabel
Biotransformation of moclobemide in humans
@ast
Biotransformation of moclobemide in humans
@en
Biotransformation of moclobemide in humans
@nl
P2093
P1476
Biotransformation of moclobemide in humans
@en
P2093
Griesser E
Guentert TW
Oesterhelt G
Ziegler WH
P407
P577
1990-01-01T00:00:00Z